Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 3/20 | 0.58 |
| ▸ | ABCG2 | Q9UNQ0 | 2/20 | 0.49 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.49 |
| ▸ | FYN | P06241 | 1/20 | 0.49 |
| ▸ | MAPK3 | P27361 | 1/20 | 0.49 |
| ▸ | AHR | P35869 | 1/20 | 0.49 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.49 |
| ▸ | PLA2G2A | P14555 | 5/20 | 0.49 |
| ▸ | PLA2G4A | P47712 | 5/20 | 0.49 |
| ▸ | ESR1 | P03372 | 1/20 | 0.49 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.49 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.48 |
| ▸ | GABRP | O00591 | 1/20 | 0.47 |
| ▸ | GABRD | O14764 | 1/20 | 0.47 |
| ▸ | NPC1 | O15118 | 1/20 | 0.47 |
| ▸ | CA12 | O43570 | 1/20 | 0.47 |
| ▸ | TNKS | O95271 | 1/20 | 0.47 |
| ▸ | CA1 | P00915 | 1/20 | 0.47 |
| ▸ | CA2 | P00918 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29598277 | 1.00 | MAOB (0.58) | MAOBABCG2CYP1A1CYP1A2FYN | |
| SCHEMBL25465700 | 0.98 | MAOB (0.57) | MAOBABCG2CYP1A1CYP1A2FYN | |
| SCHEMBL25056588 | 0.97 | MAOB (0.55) | MAOBABCG2CYP1A1CYP1A2FYN | |
| SCHEMBL25465740 | 0.95 | MAOB (0.57) | MAOBABCG2CYP1A1CYP1A2FYN | |
| SCHEMBL25012942 | 0.91 | MAOB (0.50) | MAOBABCG2CYP1A1CYP1A2FYN | |
| SCHEMBL29315831 | 0.91 | MAOB (0.50) | MAOBABCG2CYP1A1CYP1A2FYN | |
| SCHEMBL25056557 | 0.91 | PLA2G2A (0.51) | MAOBABCG2CYP1A1CYP1A2FYN | |
| SCHEMBL25465826 | 0.90 | MAOB (0.51) | MAOBABCG2CYP1A1CYP1A2FYN | |
| SCHEMBL25012028 | 0.89 | MAOB (0.51) | MAOBABCG2CYP1A1CYP1A2FYN | |
| SCHEMBL25056533 | 0.88 | MAOB (0.50) | MAOBABCG2CYP1A1CYP1A2FYN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230143961-A1 | NOVEL ANTHRACENE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | SFC CO., LTD. (KR) | 2023-05-11 | — | — | US | disclosed |
| US-20230143961-A1 | NOVEL ANTHRACENE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | SFC CO., LTD. (KR) | 2023-05-11 | — | — | US | disclosed |
| EP-4137486-A1 | NOVEL ANTHRACENE COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME | SFC Co., Ltd. (KR) | 2023-02-22 | — | — | EP | disclosed |
| US-20220162222-A1 | ELECTROACTIVE COMPOUNDS | U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS NOTES COLLATERAL AGENT | 2022-05-26 | — | — | US | disclosed |
| CN-114514225-A | Electroactive compounds | 杜邦电子公司 | 2022-05-17 | — | — | CN | disclosed |
| WO-2021021840-A1 | ELECTROACTIVE COMPOUNDS | DUPONT ELECTRONICS, INC. (US) | 2021-02-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230143961-A1 | NOVEL ANTHRACENE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | CRY2, TRPA1, ANXA1 | MAOB 591/4885ABCG2 2279/4885CYP1A1 10/4885 |
| US-20220162222-A1 | ELECTROACTIVE COMPOUNDS | KCNQ1, CYP1A1, AHR | MAOB 500/4885ABCG2 365/4885CYP1A1 2/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.